| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |